Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus
about
Human T cell aging and the impact of persistent viral infectionsVaccination for hepatitis C virus: closing in on an evasive targetTransient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signalingProgrammed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapyOvercoming T cell exhaustion in infection and cancerT cell memory in the context of persistent herpes viral infectionsT cell responses in hepatitis C virus infection: historical overview and goals for future researchHuman serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionRegulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infectionT cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.Different Levels of T-Cell Receptor Triggering Induce Distinct Functions in Hepatitis B and Hepatitis C Virus-Specific Human CD4+ T-Cell ClonesStealth and cunning: hepatitis B and hepatitis C viruses.Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury.Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope GlycoproteinSOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell functionHuman Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent VirusesComprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted SpecificitiesComparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection.Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and CViral and immunological determinants of hepatitis C virus clearance, persistence, and disease.The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunityKinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered ChimpanzeesEvidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus InfectionManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingPD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 ExhaustionMultispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearanceInterferon-gamma is produced by CD8+ T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus lossRelation between viral fitness and immune escape within the hepatitis C virus proteaseLiver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 ExpressionCellular immune responses against hepatitis C virus: the evidence base 2002Clearance of low levels of HCV viremia in the absence of a strong adaptive immune responseUpregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune DysfunctionMemory CD8+ T cells are required for protection from persistent hepatitis C virus infectionCD8 Epitope Escape and Reversion in Acute HCV InfectionCellular immune selection with hepatitis C virus persistence in humansVariable Patterns of Programmed Death-1 Expression on Fully Functional Memory T Cells after Spontaneous Resolution of Hepatitis C Virus InfectionLack of Disease Specificity Limits the Usefulness of In Vitro Costimulation in HIV- and HCV-Infected PatientsDifferences in Hepatitis C Virus (HCV)-Specific CD8 T-Cell Phenotype during Pegylated Alpha Interferon and Ribavirin Treatment Are Related to Response to Antiviral Therapy in Patients Chronically Infected with HCVT cells with regulatory activity in hepatitis C virus infection: what we know and what we don'tImpaired Hepatitis C Virus (HCV)-Specific Effector CD8+ T Cells Undergo Massive Apoptosis in the Peripheral Blood during Acute HCV Infection and in the Liver during the Chronic Phase of Infection
P2860
Q21131206-F0A78BCB-D95C-4BA7-90CB-894DB643AD97Q22305922-F1E5CE73-B20E-4666-9766-B16B6B275A4EQ24630036-1C5066F0-0D85-4377-B202-B4ECF06A5A9BQ26781481-902E99E3-45D6-4A8C-AD4D-7D9B295A1C69Q26829885-4BB88679-6ED6-4B12-AA48-2C2B3B565D17Q26999125-7AC26BA1-4EC0-48E9-A28D-3572ADF0444DQ27003510-05329A2A-B217-44C8-A29A-07C16977A164Q27469507-DE395E3F-C94C-435C-83E6-272E81F1D8BFQ27469828-0E0DB3A6-8433-4FFF-B9C1-506497F81A5DQ27469830-F6FC39B3-53F4-437B-919C-5806F19B2CC1Q27469939-E291BAB4-1C98-4393-B69A-75722754E904Q27470232-417375A3-D64F-43E0-A3E8-9F1B7CEDF3DBQ27470502-7B06505F-BB43-409D-9F28-06E2B89F4D75Q27470798-248C914B-1FCA-48D8-972B-19F119352954Q27472767-2CA3BEFE-54D7-4946-BDE3-DE217A50DE50Q27472844-1B6B07C0-A9EB-4747-B39F-0A4D412B7D4EQ27472881-70027EDE-F64A-4C2C-94FD-5009F07C2629Q27472916-CC68E14B-C838-48A7-932D-8DAA922D0234Q27472920-119407BA-4542-4CAA-84AA-B3F7F743982EQ27473001-FD8C46B8-4A88-4CF0-A97F-FDA8514B2F4DQ27473081-A7F03560-026E-4AA3-99A1-D29B4DC814AFQ27473402-A5794203-5424-4000-A3D5-B9EE74F82080Q27477614-59385050-31C5-4A91-ACC2-BC2D249B068DQ27477626-09C56E33-3752-4DD9-9526-DF4C5AC155D7Q27477628-7024A00E-508C-40E9-961E-26C56D5AAB81Q27477974-077196F3-FF6B-4163-B110-122AE446848FQ27478124-0B301420-D29F-49DD-B28E-A9DA30826979Q27478333-0850ADBA-F7B6-44C4-B31B-0B43BEEE645AQ27478366-C034365A-6235-4548-8382-71C243F7DDB1Q27480725-CC26C914-E654-4D32-93D0-7CA461296C96Q27480809-06862F4F-23A1-42FC-A758-1F67864B6F84Q27481027-488D2353-91EB-4F80-8E1F-CDEF3110C33FQ27485119-9FEE5976-F1CF-4B34-9D70-73BEC63A80F2Q27485189-52D8E70B-C87A-47D1-9C48-05E618611FE2Q27485219-B8F9C415-4C4B-40E6-87E2-519EFF644F8CQ27485900-69F9F9C0-CC49-40A1-98DA-C3A875D12044Q27486527-AEF85E8C-CF15-4A28-A11E-02063BB22602Q27486579-FDD5252D-5044-48EB-8F86-198F195D1E2DQ27486637-0167570A-1962-4035-8C9F-8D9354BA57F6Q27487035-23109B05-D014-4B1A-889F-8321CC8A2284
P2860
Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Sustained Dysfunction of Antiv ...... fection with Hepatitis C Virus
@ast
Sustained Dysfunction of Antiv ...... fection with Hepatitis C Virus
@en
Sustained Dysfunction of Antiv ...... fection with Hepatitis C Virus
@nl
type
label
Sustained Dysfunction of Antiv ...... fection with Hepatitis C Virus
@ast
Sustained Dysfunction of Antiv ...... fection with Hepatitis C Virus
@en
Sustained Dysfunction of Antiv ...... fection with Hepatitis C Virus
@nl
prefLabel
Sustained Dysfunction of Antiv ...... fection with Hepatitis C Virus
@ast
Sustained Dysfunction of Antiv ...... fection with Hepatitis C Virus
@en
Sustained Dysfunction of Antiv ...... fection with Hepatitis C Virus
@nl
P2093
P2860
P3181
P1433
P1476
Sustained Dysfunction of Antiv ...... fection with Hepatitis C Virus
@en
P2093
H Diepolder
J Sullivan
N H Gruener
R Phillips
P2860
P304
P3181
P356
10.1128/JVI.75.12.5550-5558.2001
P577
2001-06-01T00:00:00Z